AI Therapeutics in Guilford tests drug as potential COVID-19 treatment

A Connecticut company is using a drug it developed to try and fight against COVID-19.

News 12 Staff

Aug 25, 2020, 6:44 PM

Updated 1,387 days ago

Share:

A Connecticut company is using a drug it developed to try and fight against COVID-19.
Sen. Chris Murphy visited AI Therapeutics in Guilford Tuesday, which has developed the new drug Apilimod to treat non-Hodgkin lymphoma and Lou Gehrig's disease.
The company says it has just been approved for phase two clinical trials with COVID-19 patients.
Murphy says when it comes to battling the pandemic, we can't pin all of our hopes or efforts on a future vaccine.
Researchers say early tests are promising for preventing an infected person from developing pneumonia, but that the drug may also be able to prevent infection before it happens.
 


More from News 12